Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes mellitus and COVID-19: Understanding the association in light of current evidence
Saikat Sen, Raja Chakraborty, Pratap Kalita, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 28, pp. 8327-8339
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

SARS‐CoV‐2 infection and multi-organ system damage: a review
Ali A. Rabaan, Samira Smajlović, Hüseyin Tombuloğlu, et al.
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 64
CDC-WONDER Database Analysis of COVID-19 and Diabetes Mellitus-Related Mortality
Armaan Jamal
Research Square (Research Square) (2025)
Closed Access
Lifestyle and Biochemical Parameters That May Hamper Immune Responses in Pediatric Patients After Immunization with the BNT162b2 mRNA COVID-19 Vaccine
Anthie Damianaki, Antonios Marmarinos, Margaritis Avgeris, et al.
Diseases (2025) Vol. 13, Iss. 3, pp. 78-78
Open Access
Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19
Sandro Satta, Sarah J. Rockwood, Kaidong Wang, et al.
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1405-1424
Open Access | Times Cited: 13
Side Effects of COVID-19 Vaccines Among Diabetic Subjects and Healthy Individuals
Fareena Khan, Muhammad Taimur Khan, Sana Zaman, et al.
Cureus (2023)
Open Access | Times Cited: 10
AstraZeneca COVID-19 Vaccine and Diabetes Mellitus: A Prospective Clinical Study Regarding Vaccine Side Effects
Nabila Rasheed, Javeria Khan, Anusha Yusuf, et al.
Cureus (2024)
Open Access | Times Cited: 3
Covid-19 infection in children and adolescents and its association with type 1 diabetes mellitus (T1d) presentation and management
Kyriaki Karavanaki, Kalliopi Rodolaki, Alexandra Soldatou, et al.
Endocrine (2022) Vol. 80, Iss. 2, pp. 237-252
Open Access | Times Cited: 17
Evaluation of MicroRNA Expression Pattern (miR-28, miR-181a, miR-34a, and miR-31) in Patients with COVID-19 Admitted to ICU and Diabetic COVID-19 Patients
Alireza Khatami, Mohammad Taghizadieh, Javid Sadri Nahand, et al.
Intervirology (2023), pp. 63-76
Open Access | Times Cited: 9
Global acceptance of COVID-19 vaccine among persons with diabetes: A systematic review and meta-analysis
Emmanuel Ekpor, Samuel Akyirem
Diabetes Research and Clinical Practice (2023) Vol. 201, pp. 110731-110731
Open Access | Times Cited: 8
Understanding long COVID myocarditis: A comprehensive review
Arti Srivastava, Shankar Nalroad Sundararaj, Jagriti Bhatia, et al.
Cytokine (2024) Vol. 178, pp. 156584-156584
Closed Access | Times Cited: 2
The Roles of Glutathione and Oxidative Stress in Diabetes and COVID-19
Evan Los, George S. Ford, Dawn Tuell, et al.
(2024)
Open Access | Times Cited: 2
Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19
Yuan-Yuan Yong, Li Zhang, Yu-Jiao Hu, et al.
Clinical Immunology (2022) Vol. 244, pp. 109093-109093
Open Access | Times Cited: 12
Connections between Diabetes Mellitus and Metabolic Syndrome and the Outcome of Cardiac Dysfunctions Diagnosed during the Recovery from COVID-19 in Patients without a Previous History of Cardiovascular Diseases
Cristina Tudoran, Renata Bende, Felix Bende, et al.
Biology (2023) Vol. 12, Iss. 3, pp. 370-370
Open Access | Times Cited: 5
Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease
Anna Allué‐Guardia, Jordi B. Torrelles, Alex Sigal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Effect of herbal extracts and Saroglitazar on high-fat diet-induced obesity, insulin resistance, dyslipidemia, and hepatic lipidome in C57BL/6J mice
Deepika Kumari, Jyoti Gautam, Vipin Sharma, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22051-e22051
Open Access | Times Cited: 5
Comparative Analysis of COVID-19 Outcomes in Type 1 and Type 2 Diabetes: A Three-Year Retrospective Study
Flavius Cioca, Romulus Timar, Flavia Ignuta, et al.
Medicina (2024) Vol. 60, Iss. 2, pp. 210-210
Open Access | Times Cited: 1
Impact Of body Mass Index on Cardiopulmonary Outcomes of COVID-19 Hospitalizations Complicated by Severe Sepsis
Sivaram Neppala, Himaja Dutt Chigurupati, Nikhilender Nag Mopuru, et al.
Obesity Pillars (2024) Vol. 10, pp. 100101-100101
Open Access | Times Cited: 1
New-Onset Diabetes Mellitus after COVID-19: Combined Effects of SARS-CoV-2 Variants, Molecular Mimicry, and m6A RNA Methylation
Jorge Luis Batista-Roche, Marian Mirabent-Casals, Dahís Manzanares, et al.
COVID (2024) Vol. 4, Iss. 4, pp. 481-494
Open Access | Times Cited: 1
Diabetes and Infectious Diseases with a Focus on Melioidosis
Asqwin Uthaya Kumar, Muhammad Ahmad Zan, Chyan-Leong Ng, et al.
Current Microbiology (2024) Vol. 81, Iss. 7
Closed Access | Times Cited: 1
Evaluating the Utility of Clinical Scores APACHE, CURB, SOFA, and NEWS2 at Admission and 5-Days after Symptom Onset in Predicting Severe COVID-19 in Patients with Diabetes
Radu Ion, Jaya Shankar Sai Kumar Kimidi, Chaitanya Kalapala, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 868-868
Open Access | Times Cited: 1
The Roles of Glutathione and Oxidative Stress in Diabetes and COVID-19
Evan Los, George S. Ford, Dawn Tuell, et al.
Oxygen (2024) Vol. 4, Iss. 3, pp. 351-362
Open Access | Times Cited: 1
COVID-19, the escalation of diabetes mellitus and the repercussions on tuberculosis
Pei Min Thong, Hai Tarng Chong, Anabel J.W. Chang, et al.
International Journal of Infectious Diseases (2023) Vol. 130, pp. S30-S33
Open Access | Times Cited: 4
Role of inflammation in determining the severity of COVID-19 infection in patients with diabetes: A comparative study
Besher Gharaibeh, Sawsan Abuhammad, Obieda Haneyah, et al.
Medicine (2023) Vol. 102, Iss. 50, pp. e36641-e36641
Open Access | Times Cited: 4
Clinical characteristics and high risk factors of patients with Omicron variant strain infection in Hebei, China
Lihong Wang, Ting Liu, Hongjuan Yue, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 3
A metabolic blueprint of COVID-19 and long-term vaccine efficacy
Engin Berber, Deepak Sumbria, Serkan Kökkaya
Drug Metabolism and Personalized Therapy (2022) Vol. 38, Iss. 1, pp. 15-29
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top